| Report Title | Price | Action |
|---|---|---|
| Schwannoma (Non Malignant Disorders) - Drugs in Development, 2021
Schwannoma (Non Malignant Disorders) - Drugs in Development, 2021 Summary Schwannoma (Non Malignant Disorders) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| D3 Dopamine Receptor (Dopamine D3 Receptor or DRD3) - Drugs in Development, 2021
D3 Dopamine Receptor (Dopamine D3 Receptor or DRD3) - Drugs in Development, 2021 Summary D3 Dopamine Receptor (Dopamine D3 Receptor or DRD3) - Drugs...
Published: Apr-2021 | No. of Pages: 95
|
$ 3000 | |
| Solute Carrier Family 12 Member 3 (Na-Cl Cotransporter or NCC or Na-Cl Symporter or Thiazide Sensitive Sodium Chloride Cotransporter or SLC12A3) - Drugs in Development, 2021
Solute Carrier Family 12 Member 3 (Na-Cl Cotransporter or NCC or Na-Cl Symporter or Thiazide Sensitive Sodium Chloride Cotransporter or SLC12A3) - Dru...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Gastrin/Cholecystokinin Type B Receptor (Cholecystokinin 2 Receptor or CCKBR) - Drugs in Development, 2021
Gastrin/Cholecystokinin Type B Receptor (Cholecystokinin 2 Receptor or CCKBR) - Drugs in Development, 2021 Summary Gastrin/Cholecystokinin Type B Re...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Acral Lentiginous Melanoma (Oncology) - Drugs in Development, 2021
Acral Lentiginous Melanoma (Oncology) - Drugs in Development, 2021 Summary Acral Lentiginous Melanoma (Oncology) - Drugs in Development, 2021 provid...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Delta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Delta or PIK3CD or EC 2.7.1.153) - Drugs in Development, 2021
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Delta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subun...
Published: Apr-2021 | No. of Pages: 95
|
$ 3000 | |
| Squalene Monooxygenase (Squalene Epoxidase or SQLE or EC 1.14.14.17) - Drugs in Development, 2021
Squalene Monooxygenase (Squalene Epoxidase or SQLE or EC 1.14.14.17) - Drugs in Development, 2021 Summary Squalene Monooxygenase (Squalene Epoxidase...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Drugs in Development, 2021
Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Drugs in Development, 2021 Summary Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Adrenal Gland Cancer (Oncology) - Drugs in Development, 2021
Adrenal Gland Cancer (Oncology) - Drugs in Development, 2021 Summary Adrenal Gland Cancer (Oncology) - Drugs in Development, 2021 provides an overvi...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Transforming Growth Factor Beta (TGFb) - Drugs in Development, 2021
Transforming Growth Factor Beta (TGFb) - Drugs in Development, 2021 Summary Transforming Growth Factor Beta (TGFb) - Drugs in Development, 2021 prov...
Published: Apr-2021 | No. of Pages: 95
|
$ 3000 | |
| Synaptic Vesicular Amine Transporter (Monoamine Transporter or Solute Carrier Family 18 Member 2 or Vesicular Amine Transporter 2 or VAT2 or SLC18A2) - Drugs in Development, 2021
Synaptic Vesicular Amine Transporter (Monoamine Transporter or Solute Carrier Family 18 Member 2 or Vesicular Amine Transporter 2 or VAT2 or SLC18A2) ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Drugs in Development, 2021
Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Drugs in Development, 2021 Sum...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| Brenner Tumor (Oncology) - Drugs in Development, 2021
Brenner Tumor (Oncology) - Drugs in Development, 2021 Summary Brenner Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Bren...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Interferon Alpha/Beta Receptor 1 (Cytokine Receptor Class II Member 1 or Cytokine Receptor Family 2 Member 1 or Type I Interferon Receptor 1 or IFNAR1) - Drugs in Development, 2021
Interferon Alpha/Beta Receptor 1 (Cytokine Receptor Class II Member 1 or Cytokine Receptor Family 2 Member 1 or Type I Interferon Receptor 1 or IFNAR1...
Published: Apr-2021 | No. of Pages: 95
|
$ 3000 | |
| Thromboxane A2 Receptor (Prostanoid TP Receptor or TBXA2R) - Drugs in Development, 2021
Thromboxane A2 Receptor (Prostanoid TP Receptor or TBXA2R) - Drugs in Development, 2021 Summary Thromboxane A2 Receptor (Prostanoid TP Receptor or T...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Bifunctional Epoxide Hydrolase 2 (Cytosolic Epoxide Hydrolase 2 or Epoxide Hydratase or Soluble Epoxide Hydrolase or Lipid Phosphate Phosphatase or EPHX2 or EC 3.3.2.10 or EC 3.1.3.76) - Drugs in Development, 2021
Bifunctional Epoxide Hydrolase 2 (Cytosolic Epoxide Hydrolase 2 or Epoxide Hydratase or Soluble Epoxide Hydrolase or Lipid Phosphate Phosphatase or EP...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Carcinoid Tumor (Oncology) - Drugs in Development, 2021
Carcinoid Tumor (Oncology) - Drugs in Development, 2021 Summary Carcinoid Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the ...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Progesterone Receptor (Nuclear Receptor Subfamily 3 Group C Member 3 or NR3C3 or PGR) - Drugs in Development, 2021
Progesterone Receptor (Nuclear Receptor Subfamily 3 Group C Member 3 or NR3C3 or PGR) - Drugs in Development, 2021 Summary Progesterone Receptor (Nu...
Published: Apr-2021 | No. of Pages: 95
|
$ 3000 | |
| Tissue Type Plasminogen Activator (t Plasminogen Activator or Alteplase or Reteplase or Plasminogen/Activator Kringle or PLAT or EC 3.4.21.68) - Drugs in Development, 2021
Tissue Type Plasminogen Activator (t Plasminogen Activator or Alteplase or Reteplase or Plasminogen/Activator Kringle or PLAT or EC 3.4.21.68) - Drugs...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Fatty Acid Amide Hydrolase (Oleamide Hydrolase 1 or Anandamide Amidohydrolase or FAAH or EC 3.5.1.99) - Drugs in Development, 2021
Fatty Acid Amide Hydrolase (Oleamide Hydrolase 1 or Anandamide Amidohydrolase or FAAH or EC 3.5.1.99) - Drugs in Development, 2021 Summary Fatty Aci...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 |